Welcome to our dedicated page for Definitive Healthcare news (Ticker: DH), a resource for investors and traders seeking the latest updates and insights on Definitive Healthcare stock.
About Definitive Healthcare Corp. (DH)
Definitive Healthcare Corp. (Nasdaq: DH) is a leading provider of healthcare commercial intelligence, delivering actionable data and insights to organizations across the healthcare ecosystem. The company's mission is to transform data, analytics, and expertise into meaningful intelligence that enables its clients to uncover opportunities, optimize strategies, and drive growth. By leveraging a robust SaaS-based platform, Definitive Healthcare empowers clients to navigate the complexities of the healthcare market with precision and confidence.
Comprehensive Data and Analytics Platform
At the core of Definitive Healthcare's offerings is its proprietary platform, which aggregates and analyzes data on over 8,100 hospitals, 7,300 ambulatory surgery centers, 11,000 imaging centers, 38,000 long-term care facilities, 1,200 accountable care organizations (ACOs) and health information exchanges (HIEs), 197,000 physician groups, 1.3 million physicians, and 750 Canadian hospitals. This extensive dataset provides clients with unparalleled visibility into the healthcare provider landscape, enabling them to make informed decisions in areas such as market segmentation, sales execution, and product development.
Key Solutions and Products
- Monocl ExpertInsight: A comprehensive tool that delivers data on more than 15 million medical experts globally, helping pharmaceutical and medtech companies enhance Key Opinion Leader (KOL) engagement and clinical collaboration.
- Population Intelligence: Combines clinical and consumer data to enable precision marketing, allowing businesses to identify and target specific audience segments effectively.
- Carevoyance: A solution tailored for medtech sales teams, providing deep insights into provider segmentation, territory alignment, and sales tracking to streamline workflows and accelerate device adoption.
- Market Forecast: A predictive analytics tool that offers three, five, and ten-year market trend projections, helping healthcare organizations plan strategically for future demand and growth opportunities.
- DH View Suite: A mobile-enabled platform that equips sales and marketing teams with instant access to critical intelligence on healthcare professionals and organizations, enhancing productivity and client engagement.
- Monocl Conferences: A specialized solution for life sciences organizations to optimize conference planning and participation, providing insights into key presentations, trending topics, and expert engagement opportunities.
Market Position and Competitive Landscape
Operating within the rapidly evolving healthcare data analytics industry, Definitive Healthcare stands out for its depth of data, innovative solutions, and focus on healthcare-specific use cases. Its competitors include companies like IQVIA and Truveta, but Definitive Healthcare differentiates itself through its tailored SaaS offerings and the integration of predictive analytics with real-time data visualization. The company's solutions address critical challenges faced by healthcare organizations, such as identifying high-growth markets, optimizing sales territories, and enhancing patient engagement strategies.
Revenue Model and Geographic Focus
Definitive Healthcare generates the majority of its revenue through subscription-based services, offering scalable solutions that cater to organizations of all sizes. While its primary market is the United States, the company also provides data on international healthcare providers, particularly in Canada, further broadening its client base and market reach.
Challenges and Opportunities
As a data-centric organization, Definitive Healthcare faces challenges such as ensuring the accuracy and comprehensiveness of its datasets, navigating complex regulatory environments, and mitigating cybersecurity risks. However, its investments in proprietary data science, AI-driven analytics, and user-friendly interfaces position it well to address these challenges and capitalize on growing demand for healthcare intelligence solutions.
Conclusion
Definitive Healthcare Corp. is a pivotal player in the healthcare commercial intelligence space, enabling organizations to unlock new opportunities and optimize their operations through data-driven insights. With its diverse product portfolio, deep industry expertise, and commitment to innovation, Definitive Healthcare continues to shape the future of the healthcare market, providing clients with the tools they need to succeed in an increasingly competitive landscape.
Definitive Healthcare Corp. (Nasdaq: DH) announced that its Chief Financial Officer, Rick Booth, will present at the Raymond James 2023 Institutional Investors Conference on March 7, 2023, at 2:50 p.m. Eastern Time. Investors can access a live webcast of the presentation on the Definitive Healthcare investor relations website. A replay will also be available for a limited time.
Definitive Healthcare is a leader in healthcare commercial intelligence, transforming data and analytics to help clients identify market opportunities. To learn more, visit definitivehc.com.
Definitive Healthcare reported a strong performance for Q4 and full year 2022, with revenue growth of 31% to $60.6 million in Q4, and a 34% increase to $222.7 million for the year. GAAP net income improved to $6.7 million, contrasting with a loss of $14.8 million in Q4 2021. Adjusted net income also rose to $10.5 million. For 2023, the company anticipates revenue between $249.0 million and $255.0 million, reflecting a 14% year-over-year increase. The launch of the Atlas Dataset and several key customer contracts signify substantial growth potential in the healthcare intelligence market.
GovForce, a technology company focused on government contractors, has secured $2.5 million in seed equity funding led by
Definitive Healthcare (Nasdaq: DH) announced it will release its fourth quarter and full year financial results on February 23, 2023, after market close. The company will hold a conference call at 5:00 PM ET to discuss the results. Investors can listen to the event via a live audio webcast on the Definitive Healthcare Investor Relations website. The replay of the call will be available until March 9, 2023, for those who cannot attend the live session.
Definitive Healthcare specializes in healthcare commercial intelligence, aiding clients in identifying market opportunities.
Definitive Healthcare (Nasdaq: DH) announced the launch of its Atlas Dataset, a comprehensive resource for healthcare commercial intelligence. This dataset integrates information on over 15 million healthcare professionals and 300,000 organizations, positioning it as a leading tool for clients to make informed decisions. An independent survey indicated the dataset's top ranking for reference and affiliation data. It includes key components such as Atlas Reference & Affiliation, All-Payor Claims, and Prescription Claims, enhancing visibility into healthcare operations and contributing to improved market understanding.
Definitive Healthcare (Nasdaq: DH) reported a 60% increase in its Atlas Prescription Claims and significant growth in Atlas All-Payor Claims. This expansion enhances data for healthcare providers to improve patient outcomes, particularly in areas like rare diseases and oncology, with nearly 20% increases in these sectors. CEO Robert Musslewhite emphasized the value of the expanded dataset for driving commercial success, refining methodologies, and increasing patient cohort accuracy. The updated Atlas Dataset equips clients with comprehensive insights into patient care, provider behavior, and market trends.
Definitive Healthcare Corp. (Nasdaq: DH) announced its participation in the 25th Annual Needham Growth Conference. CEO Robert Musslewhite and CFO Rick Booth will present on January 11, 2023, at 11:00 a.m. ET. Interested parties can access the live webcast via the Definitive Healthcare investor relations website.
The company is recognized for its healthcare commercial intelligence, using data and analytics to assist clients in navigating market opportunities effectively.
Definitive Healthcare (Nasdaq: DH) has been recognized as one of the Top Places to Work in Massachusetts for the sixth consecutive year by The Boston Globe. The award is based on surveys of employee satisfaction, assessing factors like leadership and workplace culture. CEO Robert Musslewhite highlighted the company’s commitment to an inclusive culture and employee development. Additionally, Definitive Healthcare was named a Top Workplace in the United States by Energage. The company actively promotes diversity and engages in community support through its DefinitiveCares initiative.
Definitive Healthcare Corp. (Nasdaq: DH) has appointed Jon Maack as President effective November 3, 2022. Maack, who brings extensive experience in healthcare SaaS, will oversee product management, engineering, corporate strategy, and M&A, reporting to CEO Robert Musslewhite. Maack previously served as Chief Strategy Officer at athenahealth and held senior roles at Optum and Bain & Company. He expressed excitement about joining Definitive Healthcare, emphasizing the untapped potential in the healthcare commercial intelligence market as they aim to enhance tools for their customer base of over 3,000.
Definitive Healthcare Corp. (Nasdaq: DH) reported a 33% year-over-year revenue growth to $57.4 million for Q3 2022. The net loss narrowed to ($6.4) million from ($21.0) million in Q3 2021, representing 11% of revenue. Adjusted net income rose to $8.9 million with adjusted EBITDA at $16.4 million, or 29% of revenue. The company continues to gain traction with new customers and product launches, including Passport Express. For Q4 2022, it expects revenue between $58-59 million, a 26% increase year-over-year.
FAQ
What is the current stock price of Definitive Healthcare (DH)?
What is the market cap of Definitive Healthcare (DH)?
What does Definitive Healthcare Corp. do?
What industries does Definitive Healthcare serve?
How does Definitive Healthcare generate revenue?
What are some of Definitive Healthcare's key products?
What makes Definitive Healthcare unique in its industry?
Who are Definitive Healthcare's competitors?
What challenges does Definitive Healthcare face?
What geographic regions does Definitive Healthcare cover?
What is Monocl ExpertInsight?
How does Population Intelligence benefit businesses?
